The Federal Trade Commission (FTC) Friday, August 2, authorized an action to block Evonik Industries AG’s proposed US$625 million acquisition of PeroxyChem Holding Company, alleging the merger of the chemical companies would substantially reduce competition in the Pacific Northwest and the Southern and Central United States for the production and sale of hydrogen peroxide, a commodity chemical used for oxidation, disinfection, and bleaching.
Featured News
India Defends Global Turnover Antitrust Rule as Apple Challenges Multibillion-Dollar Fine
Jan 11, 2026 by
CPI
China Probes Food Delivery Platforms Over Competition Practices
Jan 11, 2026 by
CPI
Paramount Urges Congress to Scrutinize Netflix Deal for Warner Bros. Discovery Assets
Jan 11, 2026 by
CPI
X Claims Music Publishers Colluded to Enforce Costly Licensing Terms
Jan 11, 2026 by
CPI
EU Issues Guidance to Clarify Enforcement of Foreign Subsidies Rules
Jan 11, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi